pd 153035 has been researched along with Psoriasis in 2 studies
4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline: structure given in first source
PD-153035 : A member of the class of quinazolines carrying a 3-bromophenylamino substituent at position 4 and two methoxy substituents at positions 6 and 7.
Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thacher, SM | 1 |
| Vasudevan, J | 1 |
| Tsang, KY | 1 |
| Nagpal, S | 1 |
| Chandraratna, RA | 1 |
| Sugiura, K | 1 |
| Muro, Y | 1 |
| Futamura, K | 1 |
| Matsumoto, K | 1 |
| Hashimoto, N | 1 |
| Nishizawa, Y | 1 |
| Nagasaka, T | 1 |
| Saito, H | 1 |
| Tomita, Y | 1 |
| Usukura, J | 1 |
1 review available for pd 153035 and Psoriasis
| Article | Year |
|---|---|
New dermatological agents for the treatment of psoriasis.
Topics: Administration, Topical; Anti-Inflammatory Agents; Cholecalciferol; Clinical Trials as Topic; Glucoc | 2001 |
1 other study available for pd 153035 and Psoriasis
| Article | Year |
|---|---|
The unfolded protein response is activated in differentiating epidermal keratinocytes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; ATP-Binding Cassette Transporters; Carcinoma, Squamous C | 2009 |